GlucoTrack, Inc.(GCTK)

Medical - Devices · Rutherford, NJ

$1.11Daily change unavailable

Delayed quote: Oct 6, 2026, 12:33 PM EDT

EV/FCF Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T16:37:13.463Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:37:13.463Z.

Quote observation: 2026-10-06T16:33:13.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 885,939
Total debt · period ending 2026-06-30: 19,000
Cash · period ending 2026-06-30: 1,124,000
TTM free cash flow · period ending 2026-06-30: -16,308,000

FMP input reference: fe223a2c9097866a428bc5ebda2476775355ce68fd4daeb413d6e89482dd9b46

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

GCTK EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

GCTK Competitors' EV/FCF Ratio

GCTK

GlucoTrack, Inc.

Current

Market Cap

$885939.00

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SBFM

Sunshine Biopharma, Inc.

vs GCTK

Market Cap

$880215.00

EV/FCF Ratio

N/A

TTM Avg

13238.43x

3Y Avg

13238.43x

5Y Avg

13238.43x

BBLG

Bone Biologics Corporation

vs GCTK

Market Cap

$866810.00

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DCOY

Decoy Therapeutics Inc.

vs GCTK

Market Cap

$851096.00

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BJDX

Bluejay Diagnostics, Inc.

vs GCTK

Market Cap

$822391.00

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RDGT

Ridgetech, Inc.

vs GCTK

Market Cap

$773249.00

EV/FCF Ratio

N/A

TTM Avg

3.75x

3Y Avg

3.71x

5Y Avg

2.08x

ASBP

Aspire Biopharma Holdings, Inc.

vs GCTK

Market Cap

$1.04M

EV/FCF Ratio

N/A

TTM Avg

60793.51x

3Y Avg

60793.51x

5Y Avg

60793.51x

CMND

Clearmind Medicine Inc.

vs GCTK

Market Cap

$1.06M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CDT

CDT Equity Inc.

vs GCTK

Market Cap

$685948.00

EV/FCF Ratio

N/A

TTM Avg

2.87x

3Y Avg

2.87x

5Y Avg

2.87x

HKPD

Cellyan Biotechnology Co., Ltd

vs GCTK

Market Cap

$1.10M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
GlucoTrack, Inc. (GCTK)	$885939.00	N/A	N/A	N/A	N/A
Sunshine Biopharma, Inc. (SBFM)vs ›	$880215.00	N/A	13238.43x	13238.43x	13238.43x
Bone Biologics Corporation (BBLG)vs ›	$866810.00	N/A	N/A	N/A	N/A
Decoy Therapeutics Inc. (DCOY)vs ›	$851096.00	N/A	N/A	N/A	N/A
Bluejay Diagnostics, Inc. (BJDX)vs ›	$822391.00	N/A	N/A	N/A	N/A
Ridgetech, Inc. (RDGT)vs ›	$773249.00	N/A	3.75x	3.71x	2.08x
Aspire Biopharma Holdings, Inc. (ASBP)vs ›	$1.04M	N/A	60793.51x	60793.51x	60793.51x
Clearmind Medicine Inc. (CMND)vs ›	$1.06M	N/A	N/A	N/A	N/A
CDT Equity Inc. (CDT)vs ›	$685948.00	N/A	2.87x	2.87x	2.87x
Cellyan Biotechnology Co., Ltd (HKPD)vs ›	$1.10M	N/A	N/A	N/A	N/A

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/FCF Ratio: N/A

GCTK EV/FCF Ratio Metrics

GCTK Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

Related Metrics